TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve. April 13, 2007
TCL Archive Tobacco Regulation: ACS Advocates Giving FDA Full Authority Over Tobacco January 23, 1998
